The Impact of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with Major Vascular Invasion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Impact of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with Major Vascular Invasion

Published:2021-08-26 Issue:1 Volume:40 Page:81-89
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Kaibori Masaki¹,Matsushima Hideyuki¹,Ishizaki Morihiko¹,Kosaka Hisashi¹,Matsui Kosuke¹,Nakatani Miyuki²,Kariya Shuji²,Yamaguchi Takashi³,Yoshida Katsunori³,Yoshii Kengo⁴,Sekimoto Mitsugu¹

Affiliation:

1. Department of Surgery, Kansai Medical University, Hirakata, Japan

2. Department of Radiology, Kansai Medical University, Hirakata, Japan

3. Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Japan

4. Department of Mathematics and Statistics in Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2021.1952594

Reference27 articles.

1. Primary liver cancer: Worldwide incidence and trends

2. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study

3. Global Cancer Statistics, 2002

4. Increase in primary liver cancer in the UK, 1979–94

5. Rising Incidence of Hepatocellular Carcinoma in the United States

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma—Today and Tomorrow;International Journal of Molecular Sciences;2024-01-25

2. The worthy role of hepatic arterial infusion chemotherapy in combination with anti-programmed cell death protein 1 monoclonal antibody immunotherapy in advanced hepatocellular carcinoma;Frontiers in Immunology;2023-10-31

3. Cisplatin in Liver Cancer Therapy;International Journal of Molecular Sciences;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3